Clinical Trial: Residual Hypermethylation in Early Stage Non-Small Cell Lung Cancer (NSCLC) As Part of Adjuvant Therapy and Preventive Strategy
Sponsor and Collaborators
University of Miami Sylvester Comprehensive Cancer Center
Edgardo Santos, MD, University of Miami Sylvester Comprehensive Cancer Center
Next post in Lung Cancer Clinical Trials
Log in to continue reading this article.
Don’t miss out on today’s top content on Oncology Nurse Advisor. Register for free and gain unlimited access to:
- Clinical Updates
- Evidence-Based Guidance
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
Want to read more?
Please login or register first to view this content.